Does fibrosis severity or diabetes status influence patient-reported lifestyle changes and degree of success among non-alcoholic steatohepatitis patients?

被引：0
|
作者：
Higgins, Victoria [1 ]
Carroll, James [1 ]
Jackson, Jessica [1 ]
Gillespie-Akar, Liane [1 ]
机构：
[1] Adelphi Real World, Bollington, England
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-2343
引用
收藏
页码：S553 / S554
页数：2
相关论文
共 50 条
  • [31] UTILIZATION AND EXPENDITURES FOR NON-ALCOHOLIC STEATOHEPATITIS/NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH ADVANCE FIBROSIS AND COMPENSATED CIRRHOSIS: RESULTS OF A REAL-WORLD ANALYSIS AMONG US PATIENTS
    Wong, Robert J.
    Fulcher, Nicole
    Kent, Shia
    Gordon, Stuart C.
    GASTROENTEROLOGY, 2018, 154 (06) : S1110 - S1110
  • [32] Improvements in the ELF test are associated with widespread changes in the hepatic transcriptome in patients with advanced fibrosis due to non-alcoholic steatohepatitis
    Younossi, Zobair M.
    Anstee, Quentin
    Harrison, Stephen
    Trauner, Michael
    Lawitz, Eric
    Wong, Vincent Wai-Sun
    Okanoue, Takeshi
    Gomez, Manuel Romero
    Alazawi, William
    Gindin, Yevgeniy
    Zhou, Jing Zhu
    Camargo, Marianne
    Kersey, Kathryn
    Chung, Chuhan
    Subramanian, Mani
    Myers, Robert
    Goodman, Zachary
    Loomba, Rohit
    Rosenberg, William
    Sanyal, Arun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S528 - S530
  • [33] EARLY MENOPAUSAL STATUS IS ASSOCIATED WITH THE SEVERITY OF LIVER FIBROSIS IN ITALIAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Petta, S.
    Vanni, E.
    Valenti, L.
    Miele, L.
    Bianchini, M.
    Fracanzani, A. L.
    Bugianesi, E.
    Craxi, A.
    Fargion, S.
    Grieco, A.
    Camma, C.
    Villa, E.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E25 - E26
  • [34] EARLY MENOPAUSAL STATUS IS ASSOCIATED WITH THE SEVERITY OF LIVER FIBROSIS IN ITALIAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Petta, S.
    Vanni, E.
    Valenti, L.
    Miele, L.
    Bianchini, M.
    Fracanzani, A. L.
    Bugianesi, E.
    Craxi, A.
    Fargion, S.
    Grieco, A.
    Camma, C.
    Villa, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S343 - S343
  • [35] COMPARING FIBROSIS STAGING APPROACHES AMONG PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING REAL WORLD DATA (RWD)
    Bonafede, M.
    Fishman, J.
    Dodge, S.
    Miller, K.
    Zeng, N.
    Bogdanov, A.
    VALUE IN HEALTH, 2022, 25 (07) : S445 - S446
  • [36] THE SEVERITY OF STEATOSIS DOES NOT INFLUENCE LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Forlano, R.
    Mullish, B. H.
    Angkathunyakul, N.
    Goldin, E.
    Yee, M.
    Serviddio, G.
    Giannakeas, N.
    Tzallas, A. T.
    Tsipouras, M. G.
    Rui, F.
    Khan, S.
    Taylor-Robinson, S.
    Goldin, R. D.
    Thursz, M.
    Manousou, P.
    GUT, 2017, 66 : A174 - A174
  • [37] The severity of steatosis does not influence liver stiffness measurements in patients with Non-Alcoholic Fatty Liver Disease
    Forlano, R.
    Maurice, J.
    Mullish, B. H.
    Angkathunyakul, N.
    Goldin, E.
    Serviddio, G.
    Yee, M.
    Giannakeas, N.
    Tzallas, A. T.
    Tsipouras, M. G.
    Khan, S.
    Taylor-Robinson, S.
    Goldin, R. D.
    Thursz, M.
    Manousou, P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S586 - S587
  • [38] ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA): RESULTS FROM REGENERATE PHASE 3 CLINICAL TRIAL
    Younossi, Zobair M.
    Stepanova, Maria
    Nader, Fatema
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Harrison, Stephen A.
    Sanyal, Arun J.
    Trotter, James F.
    Sheikh, Muhammad Y.
    Montano-Loza, Aldo J.
    Olveria, Antonio
    Stinton, Laura M.
    Sheridan, David A.
    Vargas, Victor
    Gluud, Lise L.
    Safadi, Rifaat
    Schattenberg, Joern
    Khalili, Mandana
    Orr, David W.
    Peck-Radosavljevic, Markus
    Allison, Michael E.
    Cawkwell, Gail
    Wong, Bruce
    Bedossa, Pierre
    Goodman, Zachary D.
    Rinella, Mary E.
    HEPATOLOGY, 2019, 70 : 1366A - 1368A
  • [39] PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIAL
    Younossi, Zobair M.
    Stepanova, Maria
    Nader, Fatema
    Romero-Gomez, Manuel
    Okanoue, Takeshi
    Trauner, Michael H.
    Myers, Robert P.
    Djedjos, Stephen
    Harrison, Stephen A.
    Goodman, Zachary D.
    HEPATOLOGY, 2019, 70 : 1119A - 1120A
  • [40] Effect of canagliflozin on liver function tests in patients with type 2 diabetes and presumed liver fibrosis suggestive of non-alcoholic steatohepatitis
    Meininger, G.
    Polidori, D.
    DIABETOLOGIA, 2017, 60 : S412 - S413
12345